SEQUENT SCIENTIFIC Limited
RESULTS FOR THE
SECOND QUARTER ENDED SEP'2017
Q2-FY 2017-18
The Results of SEQUENT SCIENTIFIC Limited for the second quarter ended
Sep'2017 are placed here under.
Declaration : This does not constitute a Buy/Sell/Hold Recommendation.
SEQUENT
SCIENTIFIC |
Sep '17 |
Jun '17 |
Mar '17 |
Dec '16 |
Sep '16 |
Net Sales |
265.2 |
256.54 |
249.95 |
270.89 |
248.91 |
Other Operating Income |
-- |
-- |
-- |
2.19 |
1.52 |
Total Income |
265.2 |
256.54 |
249.95 |
273.08 |
250.42 |
EXPENDITURE |
|
|
|
|
|
Raw Materials |
110.36 |
117.33 |
120.66 |
107.89 |
137.5 |
Traded Goods |
16.29 |
20.75 |
23.2 |
17.82 |
1.64 |
Increase in Stocks |
13.19 |
-6.79 |
-22.88 |
14.38 |
-9.99 |
Employees Cost |
34.75 |
33.4 |
33.39 |
39.49 |
36.77 |
Depreciation |
16.02 |
15.06 |
15.66 |
18.33 |
16.47 |
Other Expenses |
54.97 |
60.33 |
58.76 |
75.09 |
64.07 |
P/L Before Other Inc., Int., Excpt. Items
& Tax |
19.63 |
16.47 |
21.18 |
0.08 |
3.97 |
Other Income |
6.73 |
3.73 |
0.08 |
5.5 |
3.3 |
P/L Before Int., Excpt. Items & Tax |
26.37 |
20.21 |
21.26 |
5.58 |
7.27 |
Interest |
9.45 |
9.5 |
9.41 |
12.13 |
9.41 |
P/L Before Tax |
16.91 |
10.71 |
11.85 |
-6.55 |
-2.15 |
Tax |
3.83 |
1.93 |
-1.14 |
1.65 |
2.3 |
P/L After Tax from Ordinary Activities |
13.08 |
8.78 |
16.71 |
-8.2 |
-4.45 |
Extra Ordinary Items |
17.46 |
-6.53 |
-6.21 |
-- |
-- |
Net Profit/(Loss) For the Period |
30.54 |
2.25 |
10.5 |
-8.2 |
-4.45 |
Minority Interest |
-- |
-- |
-- |
5.33 |
-0.71 |
Net P/L After M.I & Associates |
30.54 |
2.25 |
10.5 |
-2.87 |
-5.15 |
Equity |
48.75 |
48.75 |
48.75 |
48.75 |
48.75 |
Basic EPS |
1.21 |
0.09 |
0.28 |
-0.12 |
-0.22 |
Diluted EPS |
1.2 |
0.09 |
0.28 |
-0.12 |
-0.22 |
|
|
|
|
|
|
MP |
100 |
|
|
|
|
PE |
20.83333333 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No comments:
Post a Comment